View in EDS

Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada.

Saved in:
Bibliographic Details
Title: Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada.
Authors: Bhutani M; Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada, Kaplan A; Family Physician Airways Group of Canada, and University of Toronto, Toronto, Ontario, Canada, Kayaniyil S; Scientific Affairs, AstraZeneca, Mississauga, Canada, Jamieson K; Scientific Affairs, AstraZeneca, Mississauga, Canada, Ormsby R; Scientific Affairs, AstraZeneca, Mississauga, Canada, Bell J; BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom, Bhatt P; Milliman, New York, New York, United States, Carioto J; Milliman, New York, New York, United States, Pyenson B; Milliman, New York, New York, United States
Source: Chronic obstructive pulmonary diseases (Miami, Fla.) [Chronic Obstr Pulm Dis] 2026 May 27; Vol. 13 (3), pp. 184-194.
Publication Type: Journal Article
Journal Info: Publisher: COPD Foundation Country of Publication: United States NLM ID: 101635411 Publication Model: Print Cited Medium: Print ISSN: 2372-952X (Print) Linking ISSN: 2372952X NLM ISO Abbreviation: Chronic Obstr Pulm Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41911567
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bhutani+M%22">Bhutani M</searchLink>; Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada<br /><searchLink fieldCode="AU" term="%22Kaplan+A%22">Kaplan A</searchLink>; Family Physician Airways Group of Canada, and University of Toronto, Toronto, Ontario, Canada<br /><searchLink fieldCode="AU" term="%22Kayaniyil+S%22">Kayaniyil S</searchLink>; Scientific Affairs, AstraZeneca, Mississauga, Canada<br /><searchLink fieldCode="AU" term="%22Jamieson+K%22">Jamieson K</searchLink>; Scientific Affairs, AstraZeneca, Mississauga, Canada<br /><searchLink fieldCode="AU" term="%22Ormsby+R%22">Ormsby R</searchLink>; Scientific Affairs, AstraZeneca, Mississauga, Canada<br /><searchLink fieldCode="AU" term="%22Bell+J%22">Bell J</searchLink>; BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom<br /><searchLink fieldCode="AU" term="%22Bhatt+P%22">Bhatt P</searchLink>; Milliman, New York, New York, United States<br /><searchLink fieldCode="AU" term="%22Carioto+J%22">Carioto J</searchLink>; Milliman, New York, New York, United States<br /><searchLink fieldCode="AU" term="%22Pyenson+B%22">Pyenson B</searchLink>; Milliman, New York, New York, United States
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101635411%22">Chronic obstructive pulmonary diseases (Miami, Fla.)</searchLink> [Chronic Obstr Pulm Dis] 2026 May 27; Vol. 13 (3), pp. 184-194.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22COPD+Foundation%22">COPD Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101635411 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>2372-952X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222372952X%22">2372952X </searchLink><i>NLM ISO Abbreviation: </i>Chronic Obstr Pulm Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41911567
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.15326/jcopdf.2025.0687
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 184
    Titles:
      – TitleFull: Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bhutani M
      – PersonEntity:
          Name:
            NameFull: Kaplan A
      – PersonEntity:
          Name:
            NameFull: Kayaniyil S
      – PersonEntity:
          Name:
            NameFull: Jamieson K
      – PersonEntity:
          Name:
            NameFull: Ormsby R
      – PersonEntity:
          Name:
            NameFull: Bell J
      – PersonEntity:
          Name:
            NameFull: Bhatt P
      – PersonEntity:
          Name:
            NameFull: Carioto J
      – PersonEntity:
          Name:
            NameFull: Pyenson B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 05
              Text: 2026 May 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2372-952X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Chronic obstructive pulmonary diseases (Miami, Fla.)
              Type: main
ResultId 1